Roy Tamura

5.4k total citations
82 papers, 2.7k citations indexed

About

Roy Tamura is a scholar working on Statistics and Probability, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Roy Tamura has authored 82 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Statistics and Probability, 22 papers in Genetics and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Roy Tamura's work include Statistical Methods in Clinical Trials (28 papers), Advanced Causal Inference Techniques (14 papers) and Diabetes and associated disorders (12 papers). Roy Tamura is often cited by papers focused on Statistical Methods in Clinical Trials (28 papers), Advanced Causal Inference Techniques (14 papers) and Diabetes and associated disorders (12 papers). Roy Tamura collaborates with scholars based in United States, Sweden and Finland. Roy Tamura's co-authors include Dennis D. Boos, John H. Heiligenstein, Xiaohong Huang, Jeffrey P. Krischer, Gary D. Tollefson, David Michelson, Douglas E. Faries, Charles M. Beasley, S. Stanley Young and S. Hoog and has published in prestigious journals such as Journal of the American Statistical Association, Journal of the American College of Cardiology and American Journal of Psychiatry.

In The Last Decade

Roy Tamura

78 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roy Tamura United States	29	692	542	492	410	370	82	2.7k
Susan Spear Bassett United States	33	1.1k 1.6×	67 0.1×	238 0.5×	394 1.0×	224 0.6×	66	4.8k
Yili Lu United States	19	1.2k 1.8×	75 0.1×	168 0.3×	348 0.8×	1.7k 4.7×	32	3.4k
Gopalan Sethuraman United States	27	1.0k 1.5×	56 0.1×	498 1.0×	148 0.4×	607 1.6×	61	3.8k
Shubhabrata Mukherjee United States	31	1.1k 1.6×	172 0.3×	56 0.1×	726 1.8×	66 0.2×	79	3.1k
Brice Ozenne Denmark	22	125 0.2×	148 0.3×	1.0k 2.1×	43 0.1×	202 0.5×	105	2.5k
Hong Liu‐Seifert United States	25	1.5k 2.2×	67 0.1×	193 0.4×	63 0.2×	1.0k 2.8×	53	3.6k
Jessica B. Langbaum United States	31	2.1k 3.0×	54 0.1×	70 0.1×	163 0.4×	291 0.8×	109	3.8k
Kush Kapur United States	29	445 0.6×	123 0.2×	84 0.2×	273 0.7×	29 0.1×	97	2.6k
Michael S. Rafii United States	33	1.3k 1.9×	39 0.1×	104 0.2×	389 0.9×	470 1.3×	112	4.8k
Stephen C. Olson United States	23	661 1.0×	50 0.1×	117 0.2×	70 0.2×	91 0.2×	56	1.9k

Countries citing papers authored by Roy Tamura

Since Specialization

Citations

This map shows the geographic impact of Roy Tamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Tamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Tamura more than expected).

Fields of papers citing papers by Roy Tamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Tamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Tamura. The network helps show where Roy Tamura may publish in the future.

Co-authorship network of co-authors of Roy Tamura

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Tamura. A scholar is included among the top collaborators of Roy Tamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Tamura. Roy Tamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tamura, Roy, Laura Smith, Kimberly A. Driscoll, et al.. (2025). Children’s Understanding of Risk for Type 1 Diabetes: The TEDDY Study. Clinical Diabetes. 43(4). 461–471.

Nie, Lei, Shiowjen Lee, Haitao Chu, et al.. (2025). Challenges and Possible Strategies to Address Them in Rare Disease Drug Development: A Statistical Perspective. Clinical Pharmacology & Therapeutics. 118(1). 62–73. 1 indexed citations

Gruber, Susan, Haitao Chu, Shiowjen Lee, et al.. (2025). Use of Real‐World Data and Real‐World Evidence in Rare Disease Drug Development: A Statistical Perspective. Clinical Pharmacology & Therapeutics. 117(4). 946–960. 2 indexed citations

Tamura, Roy, et al.. (2025). SMARTs with treatment preference: Pragmatic SMART design and methods motivated by STAR*D. Contemporary Clinical Trials. 160. 108162–108162.

Warncke, Katharina, Roy Tamura, Desmond Schatz, et al.. (2024). The Influence of Pubertal Development on Autoantibody Appearance and Progression to Type 1 Diabetes in the TEDDY Study. Journal of the Endocrine Society. 8(7). bvae103–bvae103.

Aronsson, Carin Andrén, Roy Tamura, Kendra Vehik, et al.. (2023). Dietary Intake and Body Mass Index Influence the Risk of Islet Autoimmunity in Genetically At-Risk Children: A Mediation Analysis Using the TEDDY Cohort. Pediatric Diabetes. 2023. 1–11. 7 indexed citations

Johnson, Suzanne Bennett, Roy Tamura, Kerry L. McIver, et al.. (2022). The association of physical activity to oral glucose tolerance test outcomes in multiple autoantibody positive children: The TEDDY Study. Pediatric Diabetes. 23(7). 1017–1026. 1 indexed citations

Salami, Falastin, Roy Tamura, Åke Lernmark, et al.. (2022). HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children. Pediatric Diabetes. 23(8). 1586–1593. 12 indexed citations

Driscoll, Kimberly A., Roy Tamura, Suzanne Bennett Johnson, et al.. (2020). Adherence to oral glucose tolerance testing in children in stage 1 of type 1 diabetes: The TEDDY study. Pediatric Diabetes. 22(2). 360–368. 17 indexed citations

10.

Osann, Kathryn, et al.. (2020). Genetic Subtype-Phenotype Analysis of Growth Hormone Treatment on Psychiatric Behavior in Prader-Willi Syndrome. Genes. 11(11). 1250–1250. 6 indexed citations

11.

Guglin, Maya, et al.. (2019). CHEMOTHERAPY-INDUCED CARDIOMYOPATHY: ANTHRACYCLINES AND TRASTUZUMAB REQUIRE DIFFERENT APPROACH TO MONITORING AND PREVENTION. Journal of the American College of Cardiology. 73(9). 907–907. 1 indexed citations

12.

Yang, Jimin, Roy Tamura, Carin Andrén Aronsson, et al.. (2017). Maternal use of dietary supplements during pregnancy is not associated with coeliac disease in the offspring: The Environmental Determinants of Diabetes in the Young (TEDDY) study. British Journal Of Nutrition. 117(3). 466–472. 14 indexed citations

13.

Chen, Yeh‐Fong, Xiangmin Zhang, Roy Tamura, & Chiung M. Chen. (2014). A sequential enriched design for target patient population in psychiatric clinical trials. Statistics in Medicine. 33(17). 2953–2967. 10 indexed citations

14.

Mallinckrodt, Craig, Roy Tamura, & Yoko Tanaka. (2011). Recent developments in improving signal detection and reducing placebo response in psychiatric clinical trials. Journal of Psychiatric Research. 45(9). 1202–1207. 30 indexed citations

15.

Pascuzzi, Robert M., Jeremy M. Shefner, Amy S. Chappell, et al.. (2009). A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis. 11(3). 266–271. 100 indexed citations

16.

Michelson, David, et al.. (2002). Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. Journal of Psychiatric Research. 36(3). 147–152. 57 indexed citations

17.

Michelson, David, Maurizio Fava, Jay D. Amsterdam, et al.. (2000). Interruption of selective serotonin reuptake inhibitor treatment. The British Journal of Psychiatry. 176(4). 363–368. 131 indexed citations

18.

Michelson, David, Mark H. Pollack, R. Bruce Lydiard, et al.. (1999). Continuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The British Journal of Psychiatry. 174(3). 213–218. 37 indexed citations

19.

Beasley, Charles M., Mary Anne Dellva, Roy Tamura, et al.. (1999). Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol. The British Journal of Psychiatry. 174(1). 23–30. 173 indexed citations

20.

Michelson, David, R. Bruce Lydiard, Mark H. Pollack, et al.. (1998). Outcome Assessment and Clinical Improvement in Panic Disorder: Evidence From a Randomized Controlled Trial of Fluoxetine and Placebo. American Journal of Psychiatry. 155(11). 1570–1577. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact